Xu, Medina-Sánchez, et al |
Sperms are not just for baby-making
anymore, but can be used as cargo agents for delivering drugs inside the body.
Getting the chemotherapeutic agent to
only kill the tumor cells without affecting the normal cells is a dream come
true in area of cancer therapeutics because of Targeted drug delivery systems(TDDS).
Targeted drug delivery systems using polymeric
nanoparticles have opened up new avenues in cancer chemotherapy. Liposomes have shown to be effective among an
array of nano- and microcarriers but have the drawback of dilution by body
fluids, decreased penetration and uptake by non-target tissues.
Bacteria could be an alternative but
is not long before they are killed by our immune system.
Researchers at Institute for
Integrative Nanosciences in Germany and Chemnitz University of Technology are
working on innovative way to use sperms as cargo delivery agents to carry drugs
through female reproductive tract.
Mariana Medina-Sánchez and her colleagues
have developed ‘sperms’ as new ‘weapons’ for treatment of several diseases of
female reproductive tract including malignancies of genital tract, endometriosis and
PID.
Sperms offer unique advantages like
being biocompatible, self-propelling, good tissue penetration, able to soak a
large amount of drug, non-immunogenic, capacity of somatic fusion and precise
drug delivery and does not cause unnecessary drug accumulation in healthy
cells.
The sperms are coated in the desired
drug solution, then wrapped in iron suits to be guided by an external magnetic field
in the female reproductive tract. The ‘iron-suit’ consists of laser-printed 3D microstructure
(nanolithography) coated with a nanometric layer of iron with 4 arms which
release the drug soaked sperm cells in situ.
The researchers carried out this pilot
research by soaking bovine sperms in DOX-HCl (Doxorubicin) and testing this ‘tiny
weapons’ to deliver the drugs into lab-grown cancer cells called HeLa. The sperms
were successfully able to kill the standard cancer cells model, HeLa cells and HeLa
spheroids.
The research is up and available to
all the interested readers on the pre-publish website arXiv.org.
"Although there are still some
challenges to overcome before this system can be applied in in vivo
environments (e.g. imaging, biodegradation of the synthetic part, multiple
sperms carrying and delivery, and improved control of sperm release),
sperm-hybrid systems may be envisioned to be applied in in situ cancer
diagnosis and treatment in the near future," the researchers conclude in
their research.
The study
was just a proof of concept and much work remains to be done before
actual clinical application of these ‘Spermbots’, if successful it is a
breakthrough that has potential to save many lives.
The full
article can be accessed here.
No comments:
Post a Comment